rs6290
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_000812.4(GABRB1):c.975C>T(p.Ala325Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0832 in 1,613,950 control chromosomes in the GnomAD database, including 6,517 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.10 ( 999 hom., cov: 32)
Exomes 𝑓: 0.081 ( 5518 hom. )
Consequence
GABRB1
NM_000812.4 synonymous
NM_000812.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.472
Publications
19 publications found
Genes affected
GABRB1 (HGNC:4081): (gamma-aminobutyric acid type A receptor subunit beta1) The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. This gene encodes GABA A receptor, beta 1 subunit. It is mapped to chromosome 4p12 in a cluster comprised of genes encoding alpha 4, alpha 2 and gamma 1 subunits of the GABA A receptor. Alteration of this gene is implicated in the pathogenetics of schizophrenia. [provided by RefSeq, Jul 2008]
GABRB1 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 45Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.3).
BP6
Variant 4-47406821-C-T is Benign according to our data. Variant chr4-47406821-C-T is described in ClinVar as Benign. ClinVar VariationId is 1600634.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.472 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.166 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GABRB1 | NM_000812.4 | c.975C>T | p.Ala325Ala | synonymous_variant | Exon 8 of 9 | ENST00000295454.8 | NP_000803.2 | |
| GABRB1 | XM_024453976.2 | c.876C>T | p.Ala292Ala | synonymous_variant | Exon 8 of 9 | XP_024309744.1 | ||
| GABRB1 | XM_024453977.2 | c.876C>T | p.Ala292Ala | synonymous_variant | Exon 9 of 10 | XP_024309745.1 | ||
| GABRB1 | XM_017007985.2 | c.324C>T | p.Ala108Ala | synonymous_variant | Exon 4 of 5 | XP_016863474.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.104 AC: 15875AN: 152004Hom.: 992 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
15875
AN:
152004
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0910 AC: 22873AN: 251382 AF XY: 0.0934 show subpopulations
GnomAD2 exomes
AF:
AC:
22873
AN:
251382
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0809 AC: 118332AN: 1461828Hom.: 5518 Cov.: 34 AF XY: 0.0826 AC XY: 60056AN XY: 727216 show subpopulations
GnomAD4 exome
AF:
AC:
118332
AN:
1461828
Hom.:
Cov.:
34
AF XY:
AC XY:
60056
AN XY:
727216
show subpopulations
African (AFR)
AF:
AC:
5738
AN:
33480
American (AMR)
AF:
AC:
1277
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
1428
AN:
26134
East Asian (EAS)
AF:
AC:
4906
AN:
39698
South Asian (SAS)
AF:
AC:
12635
AN:
86258
European-Finnish (FIN)
AF:
AC:
5744
AN:
53418
Middle Eastern (MID)
AF:
AC:
401
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
80920
AN:
1111954
Other (OTH)
AF:
AC:
5283
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
6154
12308
18463
24617
30771
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3118
6236
9354
12472
15590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.105 AC: 15904AN: 152122Hom.: 999 Cov.: 32 AF XY: 0.107 AC XY: 7933AN XY: 74380 show subpopulations
GnomAD4 genome
AF:
AC:
15904
AN:
152122
Hom.:
Cov.:
32
AF XY:
AC XY:
7933
AN XY:
74380
show subpopulations
African (AFR)
AF:
AC:
7034
AN:
41478
American (AMR)
AF:
AC:
680
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
181
AN:
3468
East Asian (EAS)
AF:
AC:
742
AN:
5174
South Asian (SAS)
AF:
AC:
693
AN:
4814
European-Finnish (FIN)
AF:
AC:
1218
AN:
10572
Middle Eastern (MID)
AF:
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4986
AN:
68008
Other (OTH)
AF:
AC:
190
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
709
1418
2128
2837
3546
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
470
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.